Effects and outcomes after palliative surgical treatment of malignant dysphagia

References

• Cancer in Norway. Norwegian Cancer Registry, Oslo, January, 2003. ( www.kreftregisteret.no).
   Google Scholar
• Svanes K, Stangeland L, Viste A, Varhaug JE, Grønbech JE, Søreide O. Morbidity, ability to swallow, and survival, after oesophagectomy for cancer of the oesophagus and cardia. Eur J Surg 1995; 161: 669–75
   PubMedGoogle Scholar
• Law S, Wong J. Current management of esophageal cancer. J Gastrointest Surg 2005; 9: 291–310
   PubMedGoogle Scholar
• Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845–57
   PubMed Web of Science ®Google Scholar
• Lehnert T. Multimodal therapy for squamous carcinoma of the oesophagus. Br J Surg 1999; 86: 727–39
   PubMed Web of Science ®Google Scholar
• Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104–9
   PubMed Web of Science ®Google Scholar
• Blom D, Peters JH, DeMeester TR. Controversies in the current therapy of carcinoma of the esophagus. J Am Coll Surg 2002; 195: 241–50
   PubMedGoogle Scholar
• Hofmann B, Håheim LL, Søreide JA. Ethics of palliative surgery in patients with cancer. Br J Surg 2005; 92: 802–9
   PubMedGoogle Scholar
• Lilford R, Braunholtz D, Harris J, Gill T. Trials in surgery. Br J Surg 2004; 91: 6–16
   PubMedGoogle Scholar
• Alderson D, Wright PD. Laser recanalization versus endoscopic intubation in the palliation of malignant dysphagia. Br J Surg 1990; 77: 1151–3
   PubMedGoogle Scholar
• Carter R, Smith JS, Anderson JR. Laser recanalization versus endoscopic intubation in the palliation of malignant dysphagia: a randomized prospective study. Br J Surg 1992; 79: 1167–70
   PubMedGoogle Scholar
• Siersema PD, Hop WC, Dees J, Tilanus HW, van Blankenstein M. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 1998; 47: 113–20
   PubMed Web of Science ®Google Scholar
• Adam A, Ellul J, Watkinson AF, Tan BS, Morgan RA, Saunders MP, et al. Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology 1997; 202: 344–8
   PubMed Web of Science ®Google Scholar
• Angelini G, Pasini AF, Ederle A, Castagnini A, Talamini G, Bulighin G. Nd:YAG laser versus polidocanol injection for palliation of esophageal malignancy: a prospective, randomized study. Gastrointest Endosc 1991; 37: 607–10
   PubMed Web of Science ®Google Scholar
• Loizou LA, Grigg D, Atkinson M, Robertson C, Bown SG. A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology 1991; 100: 1303–10
   PubMedGoogle Scholar
• Ahlquist DA, Gostout CJ, Viggiano TR, Balm RK, Pairolero PC, Hench VS, et al. Endoscopic laser palliation of malignant dysphagia: a prospective study. Mayo Clin Proc 1987; 62: 867–74
   PubMedGoogle Scholar
• Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993; 28: 1302–7
   Google Scholar
• Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004; 23: 1497–504
   Google Scholar
• Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 2003; 52: 922–6
   PubMed Web of Science ®Google Scholar
• Segalin A, Little AG, Ruol A, Ferguson MK, Bardini R, Norberto L, et al. Surgical and endoscopic palliation of esophageal carcinoma. Ann Thorac Surg 1989; 48: 267–71
   PubMedGoogle Scholar
• Barr H, Krasner N, Raouf A, Walker RJ. Prospective randomised trial of laser therapy only and laser therapy followed by endoscopic intubation for the palliation of malignant dysphagia. Gut 1990; 31: 252–8
   PubMed Web of Science ®Google Scholar
• Carter R, Smith JS, Anderson JR. Palliation of malignant dysphagia using the Nd:YAG laser. World J Surg 1993; 17: 608–13
   PubMedGoogle Scholar
• Paolucci V, Henne T, Schmidt-Matthiesen A. Endoscopic palliative tube and laser therapy in advanced cancer of the esophagus and cardia. Chirurg 1990; 61: 43–8
   PubMedGoogle Scholar
• Naveau S, Chiesa A, Poynard T, Chaput JC. Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer. Parameters affecting long-term outcome. Dig Dis Sci 1990; 35: 294–301
   PubMedGoogle Scholar
• Spinelli P, Mancini A, Dal Fante M. Endoscopic treatment of gastrointestinal tumors: indications and results of laser photocoagulation and photodynamic therapy. Semin Surg Oncol 1995; 11: 307–18
   PubMedGoogle Scholar
• Segalin A, Bonavina L, Carazzone A, Ceriani C, Peracchia A. Improving results of esophageal stenting: a study on 160 consecutive unselected patients. Endoscopy 1997; 29: 701–9
   PubMedGoogle Scholar
• Cowling MG, Hale H, Grundy A. Management of malignant oesophageal obstruction with self-expanding metallic stents. Br J Surg 1998; 85: 264–6
   PubMed Web of Science ®Google Scholar
• Cwikiel W, Tranberg KG, Cwikiel M, Lillo-Gil R. Malignant dysphagia: palliation with esophageal stents: long-term results in 100 patients. Radiology 1998; 207: 513–8
   PubMedGoogle Scholar
• O'Sullivan GJ, Grundy A. Palliation of malignant dysphagia with expanding metallic stents. J Vasc Interv Radiol 1999; 10: 346–51
   PubMedGoogle Scholar
• Homs MY, Hansen BE, van Blankenstein M, Haringsma J, Kuipers EJ, Siersema PD. Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma. Eur J Gastroenterol Hepatol 2004; 16: 163–70
   PubMedGoogle Scholar
• McLeod RS, Wright JG, Solomon MJ, Hu X, Walters BC, Lossing A. Randomized controlled trials in surgery: issues and problems. Surgery 1996; 119: 483–6
   PubMedGoogle Scholar
• Law SY, Wong J. Esophageal cancer surgery: the value of controlled clinical trials. Semin Surg Oncol 1997; 13: 281–7
   PubMedGoogle Scholar
• Blazeby JM, Vickery CW. Quality of life in patients with cancers of the upper gastrointestinal tract. Expert Rev Anticancer Ther 2001; 1: 269–76
   PubMedGoogle Scholar
• Burdick JS. Esophageal cancer prevention, cure, and palliation. Semin Gastrointest Dis 2000; 11: 124–33
   PubMedGoogle Scholar
• Blazeby JM. Measurement of outcome. Surg Oncol 2001; 10: 127–33
   PubMed Web of Science ®Google Scholar
• van Hout BA. Whom and how to treat: weighing the costs and effects. Scand J Gastroenterol 2003; 239(Suppl)3–10
   Google Scholar